Scarica l'app Stockscreener
4.82
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Mimedx Group Inc Borsa (MDXG) Ultime notizie
MiMedx (MDXG) Launches New AMNIOFIX Thyroid Shields - GuruFocus
Thyroid surgery shield shows 76% drop in vocal nerve damage in study - Stock Titan
MiMedx Group (NASDAQ:MDXG) Sets New 1-Year LowWhat's Next? - MarketBeat
The Rosen Law Firm Files Securities Fraud Class Action Against MiMedx Group, Inc.MDXG - Yahoo
MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential - DirectorsTalk Interviews
InvestingPro Fair Value flagged MiMedx as overvalued before 47% drop By Investing.com - Investing.com Canada
Global Placenta Extract Market Size, Growth, Trends & Forecast to 2033 telaGen, BIOON, MiMedx Group - openPR.com
MiMedx Group (MDXG) Delivers Record Full Year Revenue - Finviz
MiMedx Group (NASDAQ:MDXG) Downgraded by Wall Street Zen to Buy - MarketBeat
Q2 EPS Estimates for MiMedx Group Lowered by Analyst - MarketBeat
MiMedx Group (NASDAQ:MDXG) Reaches New 1-Year LowWhat's Next? - MarketBeat
MiMedx Group (NASDAQ:MDXG) Stock Price Down 8.8%Here's What Happened - MarketBeat
MiMedx Group (MDXG) Revenue Jump To US$118.1 Million Tests Slow Growth Narrative - Sahm
MiMedx Group Q4 Earnings Call Highlights - Yahoo Finance
Transcript : MiMedx Group, Inc., Q4 2025 Earnings Call, Feb 25, 2026 - marketscreener.com
Earnings call transcript: MiMedx Q4 2025 sees robust growth, EPS beats forecast - Investing.com UK
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results - The Globe and Mail
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates - Nasdaq
MiMedx Group (NASDAQ:MDXG) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
MIMEDX Group Inc (NASDAQ:MDXG) Stock Dips Despite Strong Earnings Beat - ChartMill
MiMedx (MDXG) Q4 2025 Earnings Call Transcript - AOL.com
MiMedx: Q4 Earnings Snapshot - marketscreener.com
Earnings Flash (MDXG) MiMedx Group, Inc. Posts Q4 Adjusted EPS $0.14 per Share, vs. FactSet Est of $0.09 - marketscreener.com
Earnings Flash (MDXG) MiMedx Group, Inc. Reports Q4 Revenue $118.1M, vs. FactSet Est of $106.8M - marketscreener.com
MiMedx (MDXG) details wound-care expansion, new products and Medicare shifts - Stock Titan
MiMedx Group, Inc. announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com
What to Expect from MiMedx Group's Earnings - Benzinga
MiMedx Group Inc (MDXG) Q4 2025 Earnings Report Preview: What to Look For - GuruFocus
MiMedx Group, Inc (MDXG) Stock Analysis: Exploring an 81% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
MiMedx Group (MDXG): Citizens Initiates Coverage with Market Out - GuruFocus
MiMedx Group (NASDAQ:MDXG) Now Covered by Citizens Jmp - MarketBeat
MiMedx Group, Inc (NASDAQ:MDXG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Beyond The Numbers: 4 Analysts Discuss MiMedx Group Stock - Benzinga
This MiMedx Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Citizens Initiates Coverage of MiMedx Group (MDXG) with Market Outperform Recommendation - Nasdaq
Citizens initiates MiMedx stock with outperform on reimbursement outlook By Investing.com - Investing.com Canada
Citizens initiates MiMedx stock with outperform on reimbursement outlook - Investing.com
How The MiMedx (MDXG) Investment Story Is Resetting Around CMS And Analyst Revisions - Yahoo Finance
MiMedx Group, Inc. authorizes a Buyback Plan. - marketscreener.com
What catalysts could drive MiMedx Group Inc. stock higherJuly 2025 Market Mood & Breakout Confirmation Trade Signals - mfd.ru
MSN Money - MSN
Will MiMedx Group Inc. stock benefit from AI adoption2025 Dividend Review & AI Forecasted Entry and Exit Points - mfd.ru
Stem Cell and Regenerative Therapy Markets, 2022-2025 & - GlobeNewswire
Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading CompaniesGilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More - Yahoo Finance
Aug Swings: What’s the MACD signal for MiMedx Group Inc.Weekly Profit Summary & Safe Capital Growth Plans - mfd.ru
Is MiMedx Group Inc. stock a good pick for beginnersBuy Signal & Daily Stock Trend Reports - mfd.ru
MiMedx (NASDAQ: MDXG) COO reports 61,961-share tax withholding on vesting - Stock Titan
MiMedx Group (MDXG) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Cantor Fitzgerald Issues Pessimistic Forecast for MiMedx Group (NASDAQ:MDXG) Stock Price - MarketBeat
MiMedx Group, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - Quiver Quantitative
MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Gem With An 87.5% Potential Upside - DirectorsTalk Interviews
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25 - Bitget
MiMedx to review Q4 and full-year 2025 results on Feb. 25 call - Stock Titan
MDXG Should I Buy - Intellectia AI
MDXG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Trigran group reports 4.2% MiMedx (MDXG) stake in amended Schedule 13G - Stock Titan
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):